Sarah Hennessy

Sarah Hennessy is an accomplished scientist with extensive experience in proteomics and biochemistry. Currently serving as Scientist II at Belharra Therapeutics, Sarah has previously held roles at Pfizer, where responsibilities included global proteomics assessment and method development for targeted mass spectrometry. At Wellspring Biosciences, Sarah contributed to drug candidate advancement while managing mammalian cell lines and executing mass spec assays. Academic experience includes a research associate role at Oklahoma State University, where teaching and research in analytical biochemistry and lipid metabolism proteins were conducted. Sarah's educational background includes a Master's degree in Biochemistry and Molecular Biology and a Bachelor's degree in Biochemistry from Oklahoma State University, complemented by a study abroad program at the University of South Australia.